CytomX Therapeutics CTMX Faces Modest Decline as Support Levels Hold US First Quarter GDP Growth Revised Down to 16 Annual Rate SYPR Q3 2025 Earnings Profitability Achieved with 002 EPS Despite Stock Decline Apogee Therapeutics Secures Up to 13 Billion Strategic Financing From Blackstone Life Sciences for Zumilokibart Development RLGT Q1 2026 Earnings EPS Surges Past Estimates Driven by Operational Efficiency Edgewise Therapeutics Inc EWTW Q1 2026 Earnings Narrower Losses Bolster Investor Sentiment QUBT Q1 2026 Earnings Surprise EPS Beat Amid Continued PreRevenue Status CCU Q1 2026 Earnings EPS Surges Past Estimates Despite Market Headwinds CIFR Q1 2026 Earnings EPS Misses Estimates Stock Declines 525 MCHX Q1 2026 Earnings EPS Miss of 003 vs Breakeven Estimate Stock Rises 122 Richmond Mutual Bancorporation Q1 2026 Earnings EPS of 028 Reported Amid Banking Sector Headwinds Park Dental Partners Inc Q1 2026 Earnings EPS Surges 1157 Above Estimates Summit Hotel Properties Inc INN Q1 2026 Earnings NarrowerThanExpected Loss Per Share Despite Challenging Operating Environment